|
There was an allegation of questionable elecsys ca 19-9 results for 1 patient on a cobas e 602 module.An interference with the elecsys ca 19-9 assay was suspected.On (b)(6) 2025, the patient's result was 793.5 u/ml.On (b)(6) 2025, a new sample was obtained, and the result was 836.6 u/ml.On (b)(6) 2025, a new sample was obtained, and the result was >1000 u/ml.A dilution (1:10) was performed, and the result was 1370 u/ml.On (b)(6) 2025, a new sample was obtained, and the result was >1000 u/ml.A dilution (1:10) was performed, and the result was 1064 u/ml.The results were inconsistent with the patient's clinical diagnosis (not provided).
|
|
On (b)(6) 2026, the patient's ca 19-9 result was 149.7 u/ml.On (b)(6) 2026, the patient's ca 19-9 result was 22.4 u/ml.The qc and calibration were acceptable.The sample from (b)(6) 2025 was returned for investigation.The investigation result (792 u/ml) was consistent with the customer's result (836.6 u/ml).No interfering substance was detected in the returned sample during the investigation.The investigation did not identify a product problem.
|